Pissared Khuituan

Pissared Khuituan

Auto-generated profile, based on publicly available information

Pissared Khuituan

Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Songkhla, Thailand

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Nutrition
Verified
Journal Article
Closed access
FHFittree Hayeeawaema
Fittree Hayeeawaema
SWSantad Wichienchot
Santad Wichienchot
PKPissared Khuituan
Pissared Khuituan

1 June 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
PKPissared Khuituan
Pissared Khuituan
SKSakena K-Da
Sakena K-Da
KBKanrawee Bannob
Kanrawee Bannob
FHFittree Hayeeawaema
Fittree Hayeeawaema
SPSaranya Peerakietkhajorn
Saranya Peerakietkhajorn
NCNarattaphol Charoenphandhu
Narattaphol Charoenphandhu
Dragon fruit oligosaccharide (DFO) has a prebiotic property which improves gut health by selectively stimulating the colonic microbiota. Altering microbiota composition may affect intestinal motility. However, no study has been done to understand the DFO effects on gut motor functions. This research thus aimed to investigate the DFO effects on mice colons compared to the prebiotic fructo-oligosaccharide (FOS) and probiotic bifidobacteria. The mice in this study received distilled water; 100, 500, and 1000 mg/kg DFO; 1000 mg/kg FOS; or 109 CFU Bifidobacterium animalis daily for 1 week and some treatments for 2 weeks. Gastrointestinal transits were analysed and motility patterns, smooth muscle (SM) contractions and morphological structures of the colons were assessed. Administration of FOS, 500 and 1000 mg/kg DFO significantly increased fecal output when compared to the control group. In mice treated with FOS and bifidobacteria, gut transit time was reduced, while upper gut transit was increased in comparison to DFO groups. Spatiotemporal maps of colonic wall motions showed that DFO increased the number of colonic non-propagation contractions and fecal pellet velocity, consistent with the results from groups treated with FOS and bifidobacteria. DFO also increased the amplitude and duration of colonic SM contractions. Histological stains showed normal epithelia, crypts, goblet cells, and SM thickness in all groups. In conclusion, DFO increased colonic SM contractions without morphological change and acted as a bulk-forming and stimulant laxative to increase fecal output and intestinal motility. Thus, DFO as a dietary supplement may promote gut health and correct gastrointestinal motility disorders.

1 August 2020 in Journal of Functional Foods
Verified
Journal Article
Open access
SKSakena K-Da
Sakena K-Da
SPSaranya Peerakietkhajorn
Saranya Peerakietkhajorn
BSBrenda Siringoringo
Brenda Siringoringo
PMParadorn Muangnil
Paradorn Muangnil
SWSantad Wichienchot
Santad Wichienchot
PKPissared Khuituan
Pissared Khuituan

26 April 2023 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
FHFittree Hayeeawaema
Fittree Hayeeawaema
PMParadorn Muangnil
Paradorn Muangnil
JJJulaluk Jiangsakul
Julaluk Jiangsakul
CTchittipong Tipbunjong
chittipong Tipbunjong
NHNawiya Huipao
Nawiya Huipao
PKPissared Khuituan
Pissared Khuituan
Although constipation is a common complication of chronic kidney disease (CKD), there is no animal model that can be used to study the association between renal impairment and gastrointestinal function without interfering with the gastrointestinal tract of the model. Therefore, we determined whether adenine could induce CKD in association with gastrointestinal dysfunction. Six-week-old ICR mice were intraperitoneally injected with saline, 25, 50, or 75 mg adenine/kg body weight for 21 days. Blood urea nitrogen (BUN), plasma creatinine, and renal histopathology were evaluated. Defecation status was evaluated from defecation frequency and fecal water content. Colonic smooth muscle contraction was measured by the organ bath technique, and transepithelial electrical resistance (TEER) was measured using an Ussing chamber. In the 50 mg/kg treatment group, BUN and creatinine were significantly increased compared with control, and inflammatory cell infiltration, glomerular necrosis, tubular dilatation, and interstitial fibrosis were observed in renal tissues. Mice in this group also showed a significant decrease in defecation frequency, fecal water content, colonic motility index, and TEER. Overall, 50 mg/kg of adenine was the best dose to induce CKD with associated constipation and intestinal barrier impairment. Therefore, this adenine administration model can be recommended for CKD-associated gastrointestinal dysfunction research.

24 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
PKPissared Khuituan
Pissared Khuituan
NHNawiya Huipao
Nawiya Huipao
NJNilobon Jeanmard
Nilobon Jeanmard
STSitthiwach Thantongsakul
Sitthiwach Thantongsakul
WPWarittha Promjun
Warittha Promjun
SPSaranya Peerakietkhajorn
Saranya Peerakietkhajorn
Constipation is a symptom that is widely found in the world’s population. Various dietary supplementations are used to relieve and prevent constipation. Seaweed is widely used for its health benefits. In this study, we aimed to investigate the effects of Sargassum plagiophyllum extract (SPE) on functions of the gastrointestinal tract and gut microbiota. The results show that SPE pretreatment increased the frequency of gut contraction, leading to reduce gut transit time. SPE pretreatment also significantly increased the secretion of Cl− and reduced Na+ absorption, increasing fecal water content in constipated mice (p < 0.05). In addition, the Bifidobacteria population in cecal contents was significantly higher in constipated mice pretreated with 500 mg/kg SPE for 14 days than in untreated constipated mice (p < 0.05). Our findings suggest that SPE can prevent constipation in loperamide-induced mice. This study may be useful for the development of human food supplements from S. plagiophyllum, which prevent constipation.

13 December 2021 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
RSRattanaporn Sengkhim
Rattanaporn Sengkhim
SPSaranya Peerakietkhajorn
Saranya Peerakietkhajorn
NJNilobon Jeanmard
Nilobon Jeanmard
SPSupattra Pongparadon
Supattra Pongparadon
PKPissared Khuituan
Pissared Khuituan
CTchittipong Tipbunjong
chittipong Tipbunjong
Purpose: To evaluate the toxicity of the dried seaweed, Sargassum plagiophyllum, extract (SPE) pretreatment in constipated mice.Methods: The dried seaweed powder was mixed with distilled water and extracted by autoclave at 121°C. Antioxidant activity of the extract was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Human normal colon cells were pretreated with SPE at 0 - 100 μg/mL for 24 h before challenging them with 100 μM hydrogen peroxide (H2O2). Intracellular reactive oxygen species (ROS) were quantified using 2',7'- dichlorodihydrofluorescein diacetate (H2DCFDA). Male ICR mice were pretreated for 14 consecutive days with SPE at 100, 500 and 1,000 mg/kg or lactulose at 500 mg/kg. Body weight and food intake were recorded daily. Constipation was induced with loperamide on days 12, 13 and 14 and fecal pellets evacuated over a 4-hr period. The ileum, liver, kidney, and spleen were collected for histopathological examination.Results: The IC50 for the radical scavenging capacity of SPE was 343.90 ± 4.21 μg/mL compared to 14.14 ± 0.71 μg/mL for ascorbic acid. Pretreatment with SPE was significantly reduced ROS production in human normal colon cells. Oral administration of all doses of SPE and lactulose for 14 consecutive days had no effect on food intake or body weight when compared to the normal control group. Defecation was significantly more frequent in mice pretreated with SPE at 100 mg/kg than in the constipation control group. Histopathological examination of the ileum, liver, kidney and spleen of pretreated constipated mice revealed no toxic effect from either SPE or lactulose. On the other hand, the loss of mucus-producing cells in the ileum of constipated mice was significantly lower in mice pretreated with SPE.Conclusions: These findings support the safety of SPE supplementation and may broaden itsapplication in clinical fields as an alternative drug or supplement for constipation management.